Press Releases Archives | Page 44 of 118

Gene & cell therapy manufacturing specialist Ascend launches with over $130M of funding as expert teams merge

June 1, 2023 By Cade Hildreth, Founder & President Leave a Comment

LONDON, May 9, 2023 — Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, announces that it has launched as a facilitator for gene therapy companies to help translate product ideas into viable clinical programs.

Ascend offers process development, clinical manufacturing, and analytical and regulatory support for biotech companies working in advanced modalities requiring flexible CMC services. Originally founded by Monograph Capital, Ascend has raised a total of $132.5M, most recently completing a Series A fundraise led by Abingworth and Petrichor, supported by DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management, Digitalis Ventures and Ajinomoto Co., Inc. [Read more…]

denovoMATRIX launches high potency stem cell products

May 31, 2023 By Cade Hildreth, Founder & President Leave a Comment

DRESDEN, Germany, May. 31, 2023 — denovoMATRIX GmbH, an innovator in cell and gene therapy manufacturing, unveiled the broadening of its product portfolio with the launch of its first stem cell product at the annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Paris, France. [Read more…]

convEyXO and SomesTech Announce XomeXBio Joint Venture to Unleash Full Potential of Targeted Exosomes as drug delivery system for precision medicine

May 28, 2023 By Cade Hildreth, Founder & President Leave a Comment

The collaboration includes the development, commercialization and supply of a breakthrough platform based on SomesTech nanoengineering technology strengthened and validated by convEyXO to enable loading of exosomes capable to delivering bioactive compounds in a targeted way.

[Read more…]

Ronawk Announces the Launch of STELLα: A Groundbreaking Non-Clinical Contract Research Organization (CRO)

May 25, 2023 By Cade Hildreth, Founder & President Leave a Comment

Overland Park, KS – Ronawk, a leading biotechnology company, proudly announces the launch of STELLα, a state-of-the-art non-clinical contract research organization (CRO) dedicated to driving innovation in the life sciences industry. The addition of STELLα to Ronawk’s portfolio represents a significant milestone in the company’s growth and expansion, further solidifying its position as a strategic contributor to the region’s growing biotech ecosystem. [Read more…]

FDA-Approved Phase II Stem Cell Trial Shows Significant Improvements for Multiple Sclerosis (MS) Patients

May 7, 2023 By Cade Hildreth, Founder & President 2 Comments

The findings of this study suggest that stem cells could have major implications for treating MS and reversing patient disability even after significant progression.

The study, from the Tisch MS Research Center of New York, is the first to link stem cells with a broad array of improvements. Progressive MS patients demonstrated better outcomes in walking speeds, gray matter volume, bladder function, and biomarker indicators.

[Read more…]